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ROLE OF AGING IN MODULATING EARLY ORAL LESIONS  
AMANDA LE 
ABSTRACT  
Background: Oral squamous cell carcinoma (OSCC) is a head and neck cancer that is 
typically diagnosed in elderly patients. Because the incidence rates of OSCC increases by 
two-to-four fold in older age groups, age is considered one of the major risk factors. With 
aging, there is an accumulation of mutational changes that may initiate tumor formation 
and a growing population of senescent cells that can reprogram the microenvironment via 
soluble factors. The result of these changes can create a tumor permissive 
microenvironment. Although age is considered a risk factor in OSCC, there have not 
been many preclinical studies on the role of aging in the oral microenvironment.  
Objective: To investigate the role of aging in modulating early oral lesions in the 
microenvironment by analyzing protein localization and alterations in cellular 
phenotypes. 
Methods: Tongue sections from non-treated 12-week-old, non-treated aging 31-week-
old, and 4NQO-treated 31-week-old mice were subjected to immunohistochemical 
analyses (IHC). The sections were incubated with antibodies against anti-a-SMA, -
PDGFRb and -E-cadherin to observe changes in cellular morphology, staining intensity, 
localization and frequency of appearance.  
Results: The membranous localization of E-cadherin significantly decreased from young 
and aging normal epithelia to severe dysplasia. a-SMA expression was observed in the 
cytoplasm and at the membrane of elongated and spindle-like epithelial cells in severe 
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dysplasia. a-SMA and PDGFRb expressions were localized to blood vessels/pericytes in 
the stroma for all tissue samples. In the stroma surrounding severe epithelial dysplasia, 
there was an increase in vascular structures. While no a-SMA-positive myofibroblasts 
were found in any of the stroma, PDGFRb-positive stromal cells were found in the 
stroma of aging tissues from 4NQO-treated mice.  
Conclusions: This study provides evidence that aging has a role in modulating the 
microenvironment in the early pre-cancerous lesions. The appearance of myofibroblasts 
may have originated from senescent cell populations and the effects of the 4NQO 
carcinogen caused changes in the expression and localization of E-cadherin, a-SMA and 
PDGFRb as well as in cellular phenotypes. The changes observed in the precancerous 
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Statistics on Cancer in Aging Population  
The American Cancer Society (ACS) ranks cancer as the leading cause of death in 
the male age group 60-79 and female age group 40-79. In the male age group 40-59, 
cancer is the second leading cause of death. There are estimations that cancers of the oral 
cavity and pharynx will result in 54,010 new cases and 10,850 deaths (Siegal et al., 
2021). The average age of diagnosis of oral cancer is around 60 years old (NYU Oral 
Cancer Center, n.d.). The age-specific mortality rate increases when the incidence rates of 
oral cavity and pharynx cancers increase four-fold from 5.7 in age group 40-44 to 21.3 in 
age group 50-54 (Figure 1, Table 1). In addition, the mortality rate is dramatically higher 
in patients 65 years older when compared to patients under 65 years old (Howlader et al., 
2020). In the United States, the mortality rates from oral cavity and pharynx cancers are 
higher in males than females, and especially higher in black patients than white patients 








Figure 1. Age-Specific Rate of Oral Cavity and Pharynx Cancer Deaths, Male and 
Female, 2017. The mortality rate of cancers in the oral cavity and pharynx increases with 





Table 1. The Age-Specific Incidence Rate of Cancer in the Oral Cavity and 
Pharynx, Male and Female, 2017. The incidence rate of cancer found in the oral cavity 
and pharynx significantly increases two to four-folds in age groups 45-49 and 50-54 
when compared to age group 40-44. Taken from (U.S. Cancer Statistics Working Group, 
2020).  
  
Oral Squamous Cell Carcinoma  
The oral cavity, part of the head and neck region, comprises different tissues, 
including the tongue and buccal areas that are lined by the oral mucosal epithelium (ADA 
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Science and Research Institute, n.d.). The oral mucosal epithelium consists of an upper 
stratified squamous epithelium in contact with the lamina propria (Jones & Klein, 2013). 
There are clear distinct epithelial layers present: stratum basale, stratum spinosum, 
stratum granulosum, and stratum corneum (Figure 2). The stratum spinosum is multiple-
cell layers thick with the cells being round and large. The flat cells of the stratum 
granulosum have granules that are seen near the superficial surface (Groeger & Meyle, 
2019). The lamina propria is a layer of dense connective tissue that consists of blood 
vessels, nerves, and different cell types, including fibroblasts, lymphocytes, 
macrophages, leukocytes, and mast cells (Jones & Klein, 2013; Squier & Kremer, 2001).  
 
 
Figure 2. Keratinized Stratified Squamous Epithelium. Oral mucosa consists of a 
stratified squamous epithelium and lamina propria. Adapted from (Megías et al., 2019).  
 
Depending on the function of the particular region in the oral cavity, the oral 
mucosa has distinct phenotypes, which include masticatory mucosa, lining mucosa, and 
specialized mucosa (Groeger & Meyle, 2019). In regions that are associated with 
mastication, such as the hard palate, the masticatory mucosa epithelium is keratinized and 
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tightly attached to the underlying bone by the lamina propria. In regions that are more 
mobile, such as the cheeks, the lining mucosa epithelium is non-keratinized and the 
connective tissue is elastic (Groeger & Meyle, 2019; Squier & Kremer, 2001). The 
dorsum of the tongue is lined by specialized mucosa, which is a mix of masticatory and 
lining mucosae, and has specialized structures that include lingual papillae and taste buds 
(Groeger & Meyle, 2019; Squier & Kremer, 2001; Winning & Townsend, 2000). 
Head and neck cancer presents primarily as head and neck squamous cell 
carcinoma (HNSCC) with the oral cavity as its major anatomical subsite, where it 
presents primarily as oral squamous cell carcinoma (OSCC) (Kartha et al., 2018; Montero 
& Patel, 2015). The first stage in the development of OSCC is hyperplasia. When normal 
mucosal epithelial cells are exposed to a carcinogen, the cells will begin to proliferate 
causing overgrowth of the tissue. This stage is then followed by dysplasia, which can be 
mild, moderate, or severe, with the latter typically assessed as carcinoma in situ (CIS) 
(Johnson et al., 2020). The CIS then progresses to invasive carcinoma leading to the 
development of cellular discohesion from the primary tumor, spread to the cervical 
lymph nodes and ultimately to secondary tissue sites. As typical of other carcinomas, CIS 
cells can infiltrate the underlying connective tissue by breaking through the basement 
membrane (Pai & Westra, 2009).  
Age, tobacco and alcohol are some of the most prominent risk factors that 
contribute to the initiation and progression of OSCC. Compared to younger adults, there 
is a higher association of OSCC with older adults due to risk factors such as human 
papillomavirus (HPV) infection, tobacco use and alcohol consumption (Chi et al., 2015; 
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Kemmer et al., 2018). To study the association of tobacco and OSCC, 9,10-dimethyl-1,2-
benzanthracene (DMBA) and 4-nitroquinoline-1 oxide (4NQO) have been used in murine 
preclinical studies because these are known to induce oral carcinogenesis (Osei-Sarfo et 
al., 2013; Vitale-Cross et al., 2009).  
 
Mouse Models of Oral Carcinogenesis  
 DMBA has been a popular chemical carcinogen used in preclinical research to 
induce oral carcinogenesis in murine models because it can produce changes in the oral 
mucosa’s histology and morphology that can resemble human oral cancers (Ribeiro et al., 
2015). In the study conducted by Ribeiro et al. (2015), when the tissue was exposed to a 
tobacco-derived carcinogen, hyperplasia and dysplasia were observed, leading to the 
development of CIS, which was also seen in murine models when exposed to DMBA.  
However, there are limitations in using DMBA as a laboratory carcinogen to 
induce OSCC. One limitation is that it can initiate and promote an inflammatory 
response, necrosis, and growth of new tissue due to interference with the wound healing 
process. Because of these responses, analyses of early squamous lesions have been 
difficult (Kanojia & Vaidya, 2006; Vitale-Cross et al., 2009). In addition, DMBA-
associated OSCC tumors were not as similar in histology to human lesions (Kanojia & 
Vaidya, 2006). In terms of the mutational landscapes and tobacco carcinogenic 




To address the limitations of DMBA, a laboratory synthetic carcinogen, 4-
nitroquinoline-1-oxide (4NQO), has been used to induce experimental oral 
carcinogenesis in murine models (Kanojia & Vaidya, 2006). The tissues that were 
exposed to 4NQO were almost identical (~94 percent) to the human tissues exposed to 
tobacco carcinogens in terms of the morphology, histology, pathology (stages of tumor 
progression) and mutational landscapes (Kanojia & Vaidya, 2006; Wang et al., 2019; 
Zhang et al., 2006). These data demonstrate that the tobacco carcinogenic signature is 
better mimicked by 4NQO than DMBA (Wang et al., 2019).  
 In murine models of OSCC, 4NQO is delivered in drinking water (Vitale-Cross et 
al., 2009). Similar to when the oral mucosa is exposed to tobacco carcinogens, 4NQO 
induces oxidative stress, and the reduction of 4NQO by two types of reductases produces 
a carcinogenic metabolite, 4HAQO, which in turn forms DNA adducts (Kanojia & 
Vaidya, 2006; Osei-Sarfo et al., 2013). In addition, this carcinogen preferentially binds to 
guanine residues in mammalian cells (Kanojia & Vaidya, 2006; Tada & Tada, 1976). 
Examples of carcinogens present in tobacco that cause the reactions described in murine 
models include benzo(a)pyrene diol epoxide, anti-diol epoxide and 4-
(methylnitrosamino)-1-(-3-pyridyl)-1-butanone and their metabolic products. These 
compounds bind to specific sites on guanine residues to further induce human oral 




 Cancer and its Effects on the Stromal Microenvironment 
 Carcinomas are known to impact the stromal microenvironment or the tumor 
microenvironment (TME) to favor disease progression (Warrick et al., 2008).  The naive 
stromal microenvironment contains fibroblasts, inflammatory cells, endothelial cells, and 
pericytes among others (Naito et al., 2017). Under normal conditions, the stromal 
microenvironment acts as a barrier to protect against carcinogenesis by suppressing 
tumorigenic activity, maintaining tissue homeostasis and synthesizing the extracellular 
matrix (ECM) (Chen et al., 2015; Fane & Weeraratna, 2020). Insults to the tissue disrupt 
the microenvironment by altering the tissue architecture and promoting malignant 
phenotypes (Bissell & Hines, 2011). For example, fibroblasts develop into cancer-
associated fibroblasts (CAFs) whose key function is to remodel the extracellular matrix to 
promote tumor metastasis (Sahai et al., 2020). 
 
Age Impacts the Stromal Microenvironment  
 During the aging process, the biological and physiological processes begin to 
decline. Aging cells accumulate genomic and epigenetic alterations, coincident with an 
increase in senescence, which may cause the essential components in the TME to acquire 
oncogenic mutations leading to resistance to apoptosis and increased cell survival (Aunan 
et al., 2017; DeGregori, 2013; Zeng et al., 2018). Indeed, the aged microenvironment 
exhibits an increase in immunosuppressive features, an increase in pro-inflammatory 
cytokines, and an accumulation of senescent cells that are cleared by the immune system 
at a slower rate (Fane & Weeraratna, 2020; He & Sharpless, 2017; Rea et al., 2018).   
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 In contrast to the aged microenvironment, the young healthy microenvironment 
comprises fibroblasts that protect the microenvironment from signals generated by 
premalignant cells (Fane & Weeraratna, 2020). Also, in the young microenvironment, 
senescence plays an important role in suppressing cancer and is considered beneficial in 
early life (Campisi & d’Adda di Fagagna, 2007).  
Cellular senescence is characterized by a state in which cells do not have 
proliferative properties. This is a tumor-suppressive mechanism since it stops cells from 
acquiring malignant phenotypes upon damage (Campisi, 2013; Coppé et al., 2010). 
Senescent growth arrest can be induced and maintained by several tumor-suppressive 
pathways including p16INK4/pRB and p53/p21 (Campisi, 2013). These pathways can 
generate senescence-associated heterochromatin foci (SAHFs), which halt proliferation 
(Campisi & d’Adda di Fagagna, 2007). Cells that are undergoing senescence due to 
overexpression of tumor suppression pathways do not acquire senescence-associated 
secretory phenotype (SASP), which can have pro-tumorigenic properties (Coppé et al., 
2010). Nonetheless, accumulation of exogenic or endogenic damage (i.e. DNA damage, 
telomere dysfunction, oxidative stress) (Figure 3) promotes acquisition of SASP and the 






Figure 3. Cellular Senescence and Senescence-Associated Secretory Phenotype 
(SASP) Triggered by Multiple Types of Stimuli. Senescent cells acquire SASP when 
there is an accumulation of severe DNA damage (i.e. oncogenic mutations or strong 
mitogenic signals), leading to irreversible cell-cycle arrest. Senescent cells do not acquire 
SASP when there is an overexpression of tumor suppression pathways or cell-cycle 
inhibitors, such as p16 or p21. Taken from (Coppé et al., 2010). 
 
Aged Tumor Microenvironment  
Because aging is characterized by accumulation of different types of mutational 
changes, many cancers arise later in life (Frank, 2010). Accordingly, age is a recognized 
risk factor of certain cancers (White et al., 2014). Indeed, numerous studies have 
demonstrated that age and cancer are linked and interconnected (Aunan et al., 2017; 
DePinho, 2000). Vincent-Chong et al. (2018) studied the impact of age in oral cancer and 
found that in 65 to 70-week-old mice, there was a higher incidence of invasive OSCC and 
neoplasms when compared to 8 to 12-week-old mice, suggesting that the growth kinetics 
and disease progression of OSCC were influenced by age.  
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Increasing evidence indicates that aging is important for the multistage model of 
carcinogenesis. In order for cancer to progress, there must be aging-dependent somatic 
selection (Fane & Weeraratna, 2020; Rozhok & DeGregori, 2019). With physiological 
aging, cell populations in the stromal microenvironment are reprogrammed and can either 
become senescent or transform to malignant phenotypes (Fane & Weeraratna, 2020). For 
example, aging can result in the accumulation of SASP cells, which can alter the 
microenvironment allowing for the remodeling of the ECM thus favoring tumorigenesis 
(Coppé et al., 2010; Fane & Weeraratna, 2020). Specifically, the cell populations that can 
undergo SASP include epithelial, endothelial, fibroblasts, and stem cells (Fane & 
Weeraratna, 2020). These cells can secrete factors that can induce nearby premalignant 
cells to transform and cause angiogenic and growth activity, which disrupts the 
surrounding microenvironment (Campisi & d’Adda di Fagagna, 2007). Although an 
immune response can be initiated by the presence of senescent cells, only a fraction of 
these cells is cleared and the remaining cells may be reprogramed into tumor-reinitiating 
cells (Lee & Schmitt, 2019).  
The secretome produced by senescent cells comprises factors that promote 
tumorigenesis, including matrix metalloproteinases (MMPs), proteases, chemokines, 
cytokines, growth factors, and colony stimulating factors (Fane & Weeraratna, 2020). 
Other activities and processes associated with SASP and implicated in tumorigenesis 
include epithelial-to-mesenchymal transition and stem cell renewal and differentiation 
(Campisi & Robert, 2014).  
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Age and cancer can cause the extracellular matrix microenvironment composition 
to undergo changes in structural integrity that can promote tumorigenesis (Fane & 
Weeraratna, 2020). In a young and healthy microenvironment for soft tissues, the 
connective tissue is more elastic and looser; however, with age, the ECM becomes stiffer, 
its fibers realign, and collagen density increases due to the presence of SASP cells 
(Calhoun et al., 2016; Fane & Weeraratna, 2020; Walker et al., 2018). With the ECM 
stiffening the new environment becomes permissive to tumor growth and progression 
(Fane & Weeraratna, 2020). 
 
Effects of Aging on Cellular Components of Oral Tissues 
Epithelial Cells 
 Epithelial cells have a variety of functions, such as serving as a protective barrier 
on body surfaces, lining organs and cavities, filtering, as well as synthesizing and 
secreting necessary proteins (Groeger & Meyle, 2019; National Cancer Institute, n.d.). In 
the oral cavity, and in the oral mucosa, in particular, there are specific types of epithelial 
cells that line the oral surfaces called stratified squamous cells (Oral Cavity Histology, 
n.d.). These cells are flat or squamous in phenotype, and may or may not be keratinized 
depending on the area in the oral cavity (Groeger & Meyle, 2019).  
 In an aged microenvironment under healthy conditions, the oral mucosa displays 
decreased permeability coincident with morphological changes (Abu Eid et al., 2012; 
Squier & Kremer, 2001). With physiological aging, oral epithelial cells become flatter 
and increase in size, explaining the reduction in epithelial thickness (Abu Eid et al., 
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2012). Although limited quantitative studies have been done on aging oral epithelia 
markers, some research has been conducted on the epithelia in OSCC setting. To analyze 
the changes in epithelial cells, E-cadherin has been used as a marker to detect 
tumorigenesis in studies. Previous studies have used E-cadherin to study its role in 
inhibiting the growth of metastatic and invasive properties of tumor cells (Kalluri & 
Weinberg, 2009; Kushwaha et al., 2019; Thiery, 2002). In particular, Costa et al. (2015) 
studied the expression of EMT markers in OSCC and found that E-cadherin was reduced 
in epithelial cells. In contrast, expression of keratin 8 and keratin 18 in the oral cavity 
may be indicators of decreased survival rate and poor prognosis (Alam et al., 2011; 
Fillies et al., 2006; Moll et al., 2008). 
 
Mesenchymal Cells 
 Mesenchymal stem cells (MSCs) are stromal multipotent stem cells that aid in 
tissue structure, regeneration, and repair after an injury (Cuiffo & Karnoub, 2012). MSCs 
also produce chemokines, growth factors, and other molecules that can increase 
extracellular matrix components and interact with nearby cells via paracrine signaling 
(Cuiffo & Karnoub, 2012; Ridge et al., 2017). MSCs are located throughout numerous 
tissues to function as dormant stem cells, although they are mainly found in the bone 
marrow (Karnoub et al., 2007). With age, MSCs undergo biological changes in their 
proliferative and differentiation capacity, mitotic activity, migration, response rate, and 
rate of senescence, which all decrease respectively except for the latter (Liu et al., 2020).  
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Under normal conditions, MSCs can give rise to other stromal cells, including 
fibroblasts and endothelial cells (Cuiffo & Karnoub, 2012). However, in a TME, MSCs 
can enhance tumorigenesis and cancer cells’ metastatic potency, as reported for breast 
cancer and colorectal tumors (Cuiffo & Karnoub, 2012; Karnoub et al., 2007; Lee & 
Hong, 2017; Tsai et al., 2011; Yan et al., 2012). Studies have also shown that 
mesenchymal cells have tumor promoting properties: suppressing the immune system and 
driving metastasis and angiogenesis (Cuiffo & Karnoub, 2012; Koontongkaew, 2013). 
OSCC cells have been shown to undergo epithelial-to-mesenchymal transition 
(EMT), a process in which epithelial cells lose their apical-basal polarity and cell 
adhesion properties and gain mesenchymal cell markers (Koontongkaew, 2013; Moreno-
Bueno et al., 2008). EMT can also give rise to mesenchymal cells (Kalluri & Weinberg, 
2009). Specifically, during EMT, cells lose the epithelial cell-cell adhesion receptor, E-
cadherin, coincident with acquisition of migratory and invasive properties (Kalluri & 
Weinberg, 2009; Vered et al., 2010). Cells can start to express markers like vimentin, 
whose function is to reorganize the ECM allowing tumor cells to migrate and invade (Liu 
et al., 2015). Cells undergoing EMT can display deregulation of cell growth, increase in 
dedifferentiation and dissemination, that contribute to the metastatic properties of cancer 
cells (Kalluri & Weinberg, 2009; Thiery, 2002).  
 
Fibroblasts  
 Fibroblasts are non-epithelial and non-immune stromal cells, derived from 
primitive mesenchyme, with a number of important functions (Kalluri, 2016). Fibroblasts 
 
 15 
regulate inflammation, support wound healing and synthesize and deposit constituents of 
the ECM (Bainbridge, 2013; Kalluri & Zeisberg, 2006). In young and healthy tissues, the 
fibroblast secretome can help clear and restrict the growth of pathological cells by 
providing a growth-restrictive microenvironment (Fane & Weeraratna, 2020).  
 However, with age, the number of healthy fibroblasts decreases because the rate 
of their cell renewal declines. In addition, the aged immune system cannot work as 
effectively to clear out these populations. As a consequence, the environment becomes 
more immunosuppressive because of an increase in immunosuppressive infiltrates (Fane 
& Weeraratna, 2020). This results in an accumulation of senescent populations of 
fibroblasts, which can compromise the tissue microenvironment due to a disruption of 
homeostasis (Lawrenson et al., 2010; Parrinello et al., 2005).  
 Senescent fibroblasts also produce high energy metabolites and reactive oxygen 
species that cause DNA damage. With aging, these SASP fibroblasts undergo phenotypic 
and metabolic reprogramming, such as switching to aerobic glycolysis (Elkhattouti et al., 
2015; Fane & Weeraratna, 2020). The increase in oxidative stress due to age and SASP 
fibroblast secretome can reprogram cellular metabolism. Metabolites start to shift from 
their normal levels and cause cell proliferation and secretion of proinflammatory cells 
which contributes to the development a tumor permissive microenvironment (Elkhattouti 
et al., 2015; Wiley & Campisi, 2016).  
Fibroblasts that undergo SASP secrete factors (Table 2) that promote 
accumulation of mutations and conversion of cells to a malignant phenotype in an aged 
tissue microenvironment (Fane & Weeraratna, 2020; Parrinello et al., 2005). The 
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secretome induces ECM remodeling and promotes tumor cell survival, proliferation and 
invasion (Fane & Weeraratna, 2020; Liu & Hornsby, 2007). This is particularly important 
in an aged tissue microenvironment because in the elderly population, angiogenesis 
decreases. However, SASP fibroblasts can promote angiogenesis in aged tissue via 
secretion of angiogenic growth factors that play a role in cancer growth (Fane & 
Weeraratna, 2020). In addition, SASP fibroblasts can also influence endothelial cells to 
migrate and invade, and promote cancer cells to adhere to vessel walls or migrate to 
secondary metastatic sites (Coppé et al., 2010). 
 
Table 2. SASP Factors. SASP factors secreted by senescent fibroblasts can be soluble, 
insoluble, or proteases. These factors can affect nearby cells via paracrine signaling by 
triggering transduction pathways that promote cancer progression in aged tissues. This is 
a non-inclusive list. Adapted from (Coppé et al., 2010). 
 
• Interleukins (IL-6, IL-7, IL-13) 
• Chemokines  
• Membrane Cofactor Protein  
• Intracellular Adhesion Molecule  
• Insulin-like Growth Factor-Binding Protein  
• Fibronectin 
• Collagens 
• Growth-related Oncogene (GRO-a, GRO-b) 
• Hepatocyte Growth Factor  
• Vascular Endothelial Growth Factor  
 
 
In a study conducted by Kaur et al. (2016), the secretome of aged and senescent 
fibroblasts contained sFRP2, a Wnt antagonist that facilitated melanoma cell invasion. 
SASP fibroblasts have been shown to transform ovarian epithelial cells and promote 
epithelial neoplastic formation via secretion of growth factors involved in the remodeling 
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of the ECM (Lawrenson et al., 2010). In addition, senescent fibroblasts facilitated and 
promoted the growth of preneoplastic and malignant epithelial cells by possibly altering 
epithelial differentiation (Krtolica et al., 2001; Parrinello et al., 2005).  
In the TME, cancer-associated fibroblasts (CAFs) represent another abundant 
population of cells that play a role in tumorigenesis (Chen & Song, 2019). CAFs can 
facilitate tumorigenesis by depositing ECM components and secreting growth factors that 
take part in reconstructing the ECM to induce invasion and restrict immune cells from 
accessing tumor cells (Chen & Song, 2019; Kalluri, 2016) to alter its mechanical 
properties. Further, CAFs can support tumor growth by secreting factors that cause 
immune cells like Tregs and MDSCs to infiltrate (Kakarla et al., 2012). 
CAFs can be identified in the TME by expression of PDGFRb, which has been 
identified as a marker of stromal fibroblasts in OSCC, and a-SMA, which has been 
theorized as a predictor for invasive carcinoma because of its expression in cells 
undergoing EMT (Anggorowati et al., 2017; Kartha et al., 2016; Parikh et al., 2014; Shete 
et al., 2020). In terms of aging, Song et al. (2020) found a link between age and CAFs. 
The study revealed that in aged glioblastoma multiforme patients, the phenotype of CAFs 
changed when compared to younger patients. The secretion from CAFs in an aged 
microenvironment was significantly different (Song et al., 2020).  
 
Endothelial Cells 
 Endothelial cells line the vasculature and act as a semipermeable barrier to 
regulate the exchange of molecules and blood flow (Goncharov et al., 2017). With aging, 
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endothelial cells increase in size and become flatter (Jia et al., 2019). These senescent 
endothelial cells are associated with phenotypes that are pro-adhesive and pro-thrombotic 
that may explain the increase in age-related vascular pathologies (Khan et al., 2017). For 
instance, endothelial senescence has been associated with increased production of 
reactive oxygen species and a loss of normal vascular functions leading to endothelial 
dysfunction and vascular remodeling (Goncharov et al., 2017; Jia et al., 2019). 
Furthermore, endothelial cells can undergo endothelial-to-mesenchymal transition, and 
thus contribute to fibrosis (Goncharov et al., 2017).  
 Senescent endothelial cells can also contribute in the process of tumorigenesis. 
Protection of cancer cells can be attributed to the secretome produced by senescent 
endothelial cells (Faget et al., 2019). Like other SASP cells, their secretome includes 
interleukins and nonprotein factors, such as reactive oxygen species (Carracedo et al., 
2018; Coppé et al., 2010; Erusalimsky, 2009). These factors are important because they 
promote angiogenesis, inflammation and ECM degradation allowing tumors to grow and 
metastasize (Coppé et al., 2010; Erusalimsky, 2009; Miyao et al., 2020).  
With aging, angiogenesis declines, but the production of secreted factors from 
senescent endothelial cells can be a major driver of cancer progression (Fane & 
Weeraratna, 2020). Senescent endothelial cells can increase vascular intravasation of 
cancer cells as well as the rate of transmigration among cancer cells. These processes in 
senescent endothelial cells are facilitated by cytoskeletal changes in stress fiber formation 





 Macrophages are innate immune cells that function to release pro-inflammatory 
cytokines to clear away pathogens and foreign cells, such as tumor cells (Pathria et al., 
2019). With aging, macrophages start to differ in phenotypes causing age-related 
impairments in the immune system (Jackaman et al., 2013; Linehan & Fitzgerald, 2015). 
In young mice, the immune system is more capable of upregulating pro-inflammatory M1 
macrophage markers after stimulation (Mahbub et al., 2012). M1 macrophages are one of 
the polarization states of macrophages and when activated, they will produce a strong 
pro-inflammatory response and have a vital role in tumorigenesis (Aras & Zaidi, 2017). 
These macrophages have strong killing effects due to their secretion of cytokines, such as 
interleukins and interferon gamma, and production of nitric oxide synthase (Lin et al., 
2019; Zhou et al., 2020).  
 Compared to young mice, the macrophage population in aged mice consists 
predominately of M2 macrophages (Jackaman et al., 2013). M2 is another macrophage 
phenotype that releases anti-inflammatory cytokines, such as IL10 and transforming 
growth factor-beta (Aras & Zaidi, 2017). In response to stimuli in the microenvironment, 
macrophages may convert to M2 (Zhou et al., 2020). The conversion to M2 macrophages 
results in immune system suppression, angiogenesis and tissue remodeling favoring 
tumorigenesis (Lin et al., 2019; Zhou et al., 2020). Because of this anti-inflammatory 
state due to higher populations of M2 macrophages and their secretion of cytokines in 
aged microenvironments, such as IL-4 and transforming growth factor-beta, aged mice 
are more susceptible to pathological diseases (Jackaman et al., 2013). 
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In the setting of an aged TME, there is an increase in macrophages called M2 
tumor-associated macrophages (TAMs) (Fane & Weeraratna, 2020). The phenotype of 
TAMs is similar to M2 macrophages in cytokine secretions, markers and production of 
pro-tumorigenic effects (Aras & Zaidi, 2017). Because of their similarities to normal 
macrophages and lack of studies on specific markers, it is hard to identify these cells in 
the TME (Cassetta et al., 2016). 
 TAMs play a critical role in the progression, invasiveness, and migratory 
potential in tumorigenesis (Haque et al., 2019). Furthermore, TAMs can significantly 
enhance invasion and migration of cancer cells by promoting EMT (Aras & Zaidi, 2017; 
Fan et al., 2014; Liu et al., 2013; Liu et al., 2019). Secretion of epidermal growth factor 
(EGF) from TAMs has been shown to promote tumor cells to migrate and invade, 
coincident with poor prognosis in OSCC patients (Haque et al., 2019).  
TAMs may also assist cancer cells in intravasation and extravasation by secreting 
factors that facilitate migration and/or breakdown of the ECM near the endothelium (Aras 
& Zaidi, 2017; Lin et al., 2019). Additionally, TAMs can sense areas that are avascular 
and secrete VEGF-A, a pro-angiogenic factor, facilitating angiogenesis which allows 
cancer cells to get the nutrients and oxygen needed for progression to advanced disease 
(Aras & Zaidi, 2017; Noy & Pollard, 2014).  
 
Myeloid-Derived Suppressor Cells  
 Myeloid-derived suppressor cells (MDSCs) have potent immunosuppressive 
properties that are especially useful in the TME (Kondoh et al., 2018; Noy & Pollard, 
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2014; Tesi, 2019). They protect cancer cells from being attacked by the immune system 
and suppress T cell activity, therefore evading the immune system (Kondoh et al., 2018; 
Tesi, 2019). MDSCs have also been shown to participate in angiogenesis and EMT, 
which can further enhance cancer progression, metastasis, and invasion (Pang et al., 
2020). MDSCs infiltration has been correlated with increased invasiveness and poor 
prognosis due to poor response in immunotherapy (Pang et al., 2020; Zhong et al., 2019). 
In addition, MDSCs suppresses immunity by utilizing specific pathways that suppress T 
cell activity and enhance the function of regulatory T cells (Kondoh et al., 2018), as 
discussed below.  
In healthy young individuals, MDSC count is relatively low (Kondoh et al., 
2018). However, with aging, the number of MDSCs increases (Verschoor et al., 2013). 
The microenvironment switches towards recruiting immune infiltrates that have 
immunosuppressive properties, leading to a tumor-permissive microenvironment (Fane & 
Weeraratna, 2020). In an aged tumor microenvironment, the MDSCs levels are expanded 
coincident with immune tolerance (Kondoh et al., 2018). Importantly, depletion of 
MDSCs in an aged tumor microenvironment led to a reduction in tumor size (Fane & 
Weeraratna, 2020).  
 
Regulatory T cells  
 MDSCs along with other cytokines promote a subpopulation of T cells known as 
regulatory T cells (Tregs) (Kondĕlková et al., 2010; Tesi, 2019). The functions of Tregs 
include maintaining homeostasis and limiting immune responses in normal healthy tissue 
 
22 
(Shevyrev & Tereshchenko, 2020). However, in aging tissues, the number of Tregs 
increases coincident with a decline in immune responses in the elderly (Garg et al., 2014; 
Gregg et al., 2005).  
In addition to the decline in immune responses, higher frequencies of Tregs may 
contribute to the progression of tumorigenesis and poor response to tumor 
immunotherapy (Fane & Weeraratna, 2020; Sharma et al., 2006). For example, Tregs, 
especially Tregs expressing FOXP3, have been reported to be significantly elevated in 
OSCC and an indicator for OSCC progression (Kondoh et al., 2018; Kryczek et al., 
2009). Tregs may contribute to a tumor-permissive microenvironment by allowing the 
formation of premetastatic niches (Fane & Weeraratna, 2020).  
In an aged TME, there are increases in Treg prevalence which is correlated with 
poor clearance of tumor cells (Fessler et al., 2013). Tregs play a critical role in protecting 
the cancer cells from the immune system due to a lack of anti-tumor responses (Sharma 
et al., 2006; Tesi, 2019). In particular, Tregs protect cancer cells by either secreting 
factors or through cell-cell contact leading to the suppression of effector T cell response 
and expansion (Jackaman et al., 2013; Kalluri, 2016). Furthermore, Tregs have been 
shown to induce immune senescence during aging (i.e. senescence of effector T cells), 
leading to the decline of innate and adaptive immune responses (Garg et al., 2014; 
Kasakovski et al., 2018; Ye et al., 2012).  
 
Stem cells  
 Stem cells represent another important population of cells affected by 
physiological aging. In a young healthy microenvironment, stem cells are able to 
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suppress tumorigenesis because of their roles in tissue maintenance (DeGregori, 2013; 
Rossi et al., 2008). However, the functions of stem cells, such as their regenerative 
potential, decline in an aged microenvironment (van Deursen, 2014). With accumulation 
of genetic and epigenetic mutations as well as senescence, stem cell pools deplete over 
time leading to the decline in tissue regeneration (Franco et al., 2015; Fane & 
Weeraratna, 2020; Ruzankina & Brown, 2007).  
 However, stem cells undergoing senescence and acquiring SASP can contribute to 
tumorigenesis (Fane & Weeraratna, 2020). With age, there is deregulation of stem cell 
self-renewal leading to the transformation of stem cells to cancer stem cells (CSCs), 
which drives tumorigenesis (Franco et al., 2015; Rossi et al., 2008). Like SASP 
fibroblasts, CSCs can release SASP factors that have pro-tumorigenic properties that 






The purpose of this study was to address the role of aging in modulating epithelial 
and stromal compartments in early oral lesions. Although age is a known risk factor of 
oral squamous cell carcinoma (OSCC), there is limited preclinical research on how aging 
may contribute to alterations in oral epithelia and the associated microenvironment that 
promote tumorigenesis.  
Aim 1.  Analyze a-SMA expression and localization in the epithelial and stromal 
compartments in healthy young and aging oral tissues and in aging oral tissues from 
carcinogen- (4NQO-) treated C57BL/6 mice. 
Aim 2. Examine E-cadherin expression and localization in oral epithelia under 
conditions defined in Aim 1. 
Aim 3. Determine expression and localization of PDGFRb in the epithelial and 
stromal compartments to determine its localization along with changes in nuclear 











Immunohistochemistry (IHC) Staining  
Oral tongue tissue sections from C57BL/6 mice were examined by 
immunohistochemistry using antibodies specific to selected biomarkers of interest, a-
SMA, E-cadherin and PDGFRb. Each slide comprised a section of oral epithelium that 
served as a negative control lacking primary antibody to ensure accurate and reproducible 
staining. Some of the images were derived from different sections of the tongue, which 




 Tongue tissue sections from young (12 weeks), aging (31 weeks), and aging 
4NQO-treated (31 weeks) mice were deparaffinized and rehydrated with xylene (two 
times for total of 10 minutes), 100% ethanol (two minutes), 75% ethanol (two minutes), 
50% ethanol (two minutes) and Milli-Q water (two minutes). 
 
Antigen Retrieval 
Citric acid buffer (pH6) was used as a medium for samples incubating with anti-
a-SMA and E-Cadherin. Samples incubated with PDGFRb were placed in tris-EDTA 
buffer (pH 9). After cooling in room temperature for 30 minutes, the slides were placed 
in either phosphate-buffered saline (PBS) or tris-buffered saline (TBS) (1x).  
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Hydrogen Peroxidase Quenching and Blocking 
 Blocking of endogenous hydrogen peroxidase activity was performed by placing 
the slides in a mixture of hydrogen peroxide with either methanol or water. The slides 
were then washed with a combination of either PBS and PBS-tween (PBS-T) or TBS and 
TBS-tween (TBS-T). 
A PAP pen was used to draw hydrophobic barriers around the tissue sections to 
confine dilutions in their respective areas. Samples were then covered by 5% goat serum, 
a blocking buffer, and incubated in a humidified chamber at room temperature for one 
hour. In between the next following steps, the slides were washed with either PBS/PBS-T 
or TBS/TBS-T.  
 
Streptavidin/Biotin Blocking 
The tissue sections were then incubated in the humidified chamber with 
streptavidin following biotin solutions to block endogenous streptavidin and biotin 
activity for 15 minutes each. 
 
Primary Antibody Incubation  
The tissue sections were incubated in the humidified chamber overnight at 4°C 
with antibodies against Alpha-Smooth Muscle Actin (rabbit monoclonal anti-a-SMA, 
Cell Signaling Technology, Danvers, MA; 1:600), E-cadherin (rabbit monoclonal anti-E-
cadherin, Cell Signaling Technology, Danvers, MA; 1:400) and Platelet Derived Growth 
Factor Beta (rabbit monoclonal anti-PDGFRb, Cell Signaling Technology, Danvers, MA; 
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1:100). Primary antibody dilutions were made according to their data sheets. a-SMA and 
E-cadherin were diluted in 5% goat serum. PDGFRb was diluted in SignalStain® 
Antibody Diluent (Cell Signaling Technology #8112).  
 
Secondary Antibody Incubation 
Slides incubated with a-SMA and E-cadherin were incubated in the chamber with 
goat anti-rabbit biotinylated secondary antibody diluted in 5% goat serum for 30 minutes. 
The slides were then placed in the humidified chamber with streptavidin-horseradish 
peroxidase (Sav-HRP) for 30 minutes. For PDGFRb, the slides were incubated with 
SignalStain® Boost IHC Detection Reagent (HRP, rabbit) (Cell Signaling Technology 
#8114) in the humidified chamber for 30 minutes.  
 
Substrate/Chromagen and Counterstaining  
DAB was diluted with Stable Peroxide Buffer (ThermoFisher Kit #34001) and 
applied to each tissue section quickly. Once there was brown color development 
(approximately five minutes), the slides were quickly washed with PBS/TBS to stop 
color development. Hematoxylin was used to counterstain the sections. The slides were 
placed in hematoxylin for two minutes and then rinsed with Milli-Q water.  
  
Dehydration and Mounting  
The slides were dehydrated by immersion in 50% ethanol (two minutes), 75% 
ethanol (two minutes), 100% ethanol (two minutes), and xylene (two times for a total of 
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four minutes), respectively. Permount mounting medium and a cover slip were applied on 









General Histopathological Differences  
In the non-treated young oral epithelium (12 weeks), the basal layer was one-cell 
layer thick and clearly defined (Figure 4A). There was normal nuclear staining lacking 
abnormal mitotic figures. The rete ridges were well-defined with all of the extensions 
ending at around the same level. There were no rete ridges that were more elongated than 
the others and no detectable structural abnormalities (Figure 4A).  
The number of cell layers in the stratum spinosum in the non-treated aging 
epithelium (31 weeks) were notably decreased (Figure 4B). The thinning of the 
epithelium can be explained by the decrease in mitotic activity and cell proliferation as 
mice age. There were no changes in the nuclear staining of these cells in the epithelium. 
The rete ridges were flattened and no longer as elongated as the young rete ridges. Also, 
there was a noticeable decrease in cellularity in the lamina propria (Figure 4B).  
In the aging 4NQO-treated tissue sections, atypical histopathological features that 
have the potential to develop into cancer were observed with at least moderate-to-severe 
dysplasia extending to tissue edges. There was a presentation of atypical endophytic 
squamous proliferation. Unlike in normal epithelium of young and aging tissues, cellular 
and nuclear pleomorphism were present. The epithelial cells became elongated and 
spindle-like. There was no clear cellular orientation due to the loss of polarity and some 
of the architecture was chaotic. Cells were abnormally large and there was an increase in 
the nuclear to cytoplasmic ratio. Because of the increasing number of cells and expansion 
of the basal layer, there were appearances of bulbous rete pegs. The nuclei in these cells 
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were also abnormally large and hyperchromatic. There was presentation of abnormal 














Figure 4. The Oral Mucosa is Altered with Aging. A, The young oral keratinized (blue arrows) epithelium had multiple cell 
layers in the stratum spinosum with a defined one-cell thick basal layer (green arrows). Cellular and nuclear pleomorphism 
were not present. B, The aging oral epithelium had decreased in the number of cell layers and flattened rete ridges. A serous 
gland was located in the submucosa (black arrow).  C, In severe dysplasia, the cellular orientation was absent and the 
architecture was disorderly accompanied by nuclear and cellular pleomorphism (black arrow). D, Presentation of tripolar 
mitosis (bottom black arrow) and abnormally large nucleus (top black arrow) in severe dysplasia. Top row of sections A 
through C was imaged at 20X magnification. Bottom row of sections A through C was imaged at 40X magnification. Section 




Localization of a-SMA to Vasculature and Epithelial Dysplasia  
 In the non-treated young and aging oral mucosa tissue sections, a-SMA 
expression was localized to blood vessels/pericytes. Epithelial cells in both of these 
epithelia did not express a-SMA (Figure 5A-B). In the morphologically normal adjacent 
epithelium (AE) of the 4NQO-treated aging mice, a-SMA expression was also localized 
to blood vessels and epithelial cells did not express a-SMA (Figure 5C).  
 In the 4NQO-treated tissue sections at 31 weeks, there was a significant increase 
in vascular structures around severe dysplastic epithelium (Figure 5E). Epithelial cells in 
precancerous lesions expressed a-SMA. The majority of the a-SMA-positive cells were 
elongated and spindle-like. Some of the cells had cytoplasmic and membranous 
expression while other cells only had membranous expression (Figure 5D). Also, there 








Figure 5. a-SMA Expression Changes with Aging and Dysplasia. A-C, a-SMA expression was localized to blood 
vessels/pericytes in non-treated young, non-treated aging, and AE, respectively (red arrows). No expression of a-SMA was 
observed in the epithelium. D, a-SMA was widely expressed in severe epithelial dysplasia. Majority of a-SMA-positive 
epithelial cells were elongated (white arrows). E, There was an increase in vascular structures located near epithelial dysplasia 
(red arrows). Sections A through C were imaged at 40X magnification. Top row of sections D and E was imaged at 20X 






Localization E-Cadherin Staining  
 In the non-treated young epithelium (12 weeks), there was strong membranous 
staining of E-cadherin in the oral epithelial cells. E-cadherin staining was present on the 
basal and stratum spinosum layers, indicating that the cell-cell junctions were intact and 
stable. (Figure 5A). 
In the non-treated aging epithelium, the E-cadherin staining pattern and 
localization were similar to that of non-treated young epithelium, although the staining in 
some parts of the aging epithelium was not as prominent as in the young epithelium 
(Figure 5B).  
 Comparison of the two normal epithelia with the epithelium adjacent to the 
dysplastic region, AE, revealed similar membranous localization of E-cadherin staining 
(Figure 5C). In the non-treated aging epithelia and AE, the epithelial cells with strong 
membranous E-cadherin staining were morphologically normal (Figure 5B-C). In 
contrast, severe epithelial dysplasia exhibited a significant reduction in membranous E-
cadherin staining. Specifically, the staining was less defined and more diffuse, with 
detectable localization in the cytoplasm. While rounder cells had light membranous 
staining, suggesting weak junctional organization of E-cadherin, cells with a stretched 
and spindle-like appearance lacked a clear E-cadherin staining, suggesting a loss of cell-
cell junctions. This indicated that the dysplastic regions lacked cell-cell junctions and that 





Figure 6. E-cadherin Expression Decreases in Precancerous Lesions. A, Non-treated young epithelial cells stained 
intensely for E-cadherin with clear and defined membranous expression (black arrows). B, Some of the non-treated epithelial 
cells from aging mice expressed E-cadherin at similar staining intensities as epithelial cells from young mice while other cells 
nearby expressed less E-cadherin. C, AE also expressed similar staining patterns to both non-treated epithelial cells. D, In 
severe dysplasia, there was a noticeable reduction in staining intensity of E-cadherin (white arrows). Rounder cells retained a 
light E-cadherin staining (black arrows) while cells with spindle-like morphologies did not display detectable membranous E-
cadherin staining (white arrows). Sections A through C were imaged at 40X magnification, while the top row of section D was 




PDGFRb Expression in Epithelial Cells and Stromal Compartment 
 In both non-treated oral epithelia from young and aging mice, PDGFRb staining 
was observed in epithelial cells above the basal layer (Figure 7A-B). In contrast, there 
were very few PDGFRb-positive epithelial cells in the AE from aging 4NQO-treated 
mice. However, PDGFRb-positive epithelial cells were found in severe dysplasia. The 
staining was diffused and localized in the cytoplasm and the membrane (Figure 7D).  
 PDGFRb was also found surrounding blood vessels in both non-treated epithelia, 
aging AE and in severe dysplasia (Figure 7A-D). Significantly, PDGFRb-positive 
activated fibroblasts were only seen in aging 4NQO-treated stroma with a high frequency 
around the dysplastic regions. There was also a large population of myeloid cells 
surrounding severe dysplasia, especially around PDGFRb-positive activated fibroblasts 






Figure 7. PDGFRb Expression in Epithelial Cells and Stromal Compartment. A-D, Localization of PDGFRb to blood 
vessels in the stroma. A, Young epithelial cells expressing PDGFRb (black arrows). B, Similar pattern of expression is seen in 
the non-treated aging oral mucosa. C, 4NQO-treated AE display only a few cells expressing PDGFRb. A-C, No signs of 
PDGFRb-positive cells in the stromal cell, except for blood vessels (red arrows). D, Severe epithelial dysplasia expressing 
membranous and cytoplasmic PDGFRb. Sections A through C are imaged at 40X magnification, while the top row of section 






Figure 8. PDGFRb-Positive Fibroblasts and Myeloid Cells in Close Proximity with 
Precancerous Lesions. Activated fibroblast (green arrows) and immune cells residing in 






Cancer is a chronic disease whose incidence increases with age. Nonetheless, the 
effects of aging on tumorigenesis have been underappreciated in many preclinical studies. 
By examining the healthy young and aging microenvironment, including TME, it is 
possible to determine important changes in the epithelial and stromal components, such 
as protein expression and localization, nuclear activities, as well as alterations in cellular 
phenotypes.  Studies presented in this thesis project show that the aging process impacts 
oral epithelial architecture with accompanying changes in the microenvironment and 
provide a basis for the future exploration of the role of age in OSCC. 
The strong membranous expression of E-cadherin in normal young and aging 
epithelia indicates that stable cell-cell junctions and tissue polarity are maintained. In 
many carcinomas, the loss of E-cadherin from cell-cell junctions is coincident with an 
acquisition of a mesenchymal phenotype (Tian et al., 2011). Previous studies correlated 
the downregulation of E-cadherin in dysplasia and OSCC with an increase in 
invasiveness, which reinforced the role of E-cadherin in inhibiting tumorigenesis 
(Kushwaha et al., 2019; Nita-Lazar et al., 2009; Thiery, 2002; von Zeidler et al., 2014).  
In this study, treatment of the aging oral epithelium with 4NQO correlated with the 
development of dysplasia, a precursor of OSCC, with reduced E-cadherin staining at cell-
cell junctions. Although junctional E-cadherin was maintained in the untreated aging 
epithelium and in AE, the latter tissues presented as thinner spinous epithelial layers.  
Such a decline in epithelial layers with more restricted E-cadherin staining at cell-cell 
borders has been reported (Santos et al., 2019). It is tempting to speculate that the overall 
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decrease in E-cadherin in the spinous layers may render the oral tissue microenvironment 
more conducive to the loss of cell polarity and eventual cellular discohesion, shown by 
our group to be a feature of OSCC (Nita-Lazar et al., 2009).  
Our results show that oral epithelial cells in aging mice do not express aSMA but 
in response to the 4NQO treatment regions of severe dysplasia display low levels of E-
cadherin and express high levels of a-SMA. Similar findings have been reported before 
with aging rat kidney epithelial cells (Dong et al., 2017). This pattern of expression in the 
aging 4NQO-treated oral dysplasia may indicate that epithelial cells undergo EMT and 
acquire neoplastic features, consistent with the observed changes in cell morphology 
(Figure 5D). Since treatment with 4NQO requires substantial amount of time (16 weeks 
of treatment and 2 additional weeks following the withdrawal of 4NQO) to develop 
dysplasia, the observed presence of epithelial cells undergoing EMT in the aging oral 
epithelia from 4NQO-treated mice further suggests that aging may accelerate the effects 
of this carcinogen.  
 Both a-SMA and PDGFRb have been used to identify fibroblasts in the stroma 
of untreated and aging OSCC tissue sections (Hewitt et al., 2012; Kellermann et al.,2008; 
Mahajan et al., 2020). Furthermore, PDGFRb staining identified fibroblasts in an 
activated human OSCC stroma (Kartha et al., 2016). In this study, we only detected 
PDGFRb-positive activated fibroblasts in the aging 4NQO-treated tissue, especially 
around epithelial dysplasia. The increasing number of PDGFRb-positive activated 
fibroblasts around the dysplastic epithelium suggest that the tissue is undergoing 
pathological changes that may involve stromal activation and contribute to its progression 
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to OSCC. This could also explain the presence of a population of myeloid cells 
infiltrating the stroma in the vicinity of PDGFRb-positive fibroblasts. Possibly, 
PDGFRb-positive fibroblasts were in the process of supporting the development of 
immunosuppressive functions in these myeloid cells and becoming tumor-promoting 
myeloid cells (Monteran & Erez, 2019).  
An interesting observation in this study was our finding of PDGFRb expression in 
the nuclei of oral epithelial cells of non-treated young and, to a lesser degree, in aging 
tissues. There have been no previous reports identifying PDGFRb in normal oral 
epithelial cells. Our previous studies of human oral epithelia found PDGFRb as a reliable 
marker of CAFs in OSCC, coincident with its absence from the AE, hyperplasia, and 
OSCC epithelia (Kartha et al., 2016). Nevertheless, a recent report showed PDGFRb 
expression in cell layers above the basal layer in the AE in OSCC (Lin et al., 2020). Also, 
lung airway epithelial cells were shown to express PDGFRb with a role in regeneration 
of the epithelium (Shimizu et al., 2000). Since PDGFRb plays a role in inhibiting 
apoptosis and promoting mitosis (Lin et al., 2020), and since its nuclear translocation in 
fibroblasts has been shown to regulate chromatin remodeling (Papadopoulos, et al., 
2018), our detection of its nuclear expression in oral epithelia may reflect its role in 
promoting proliferation in a young tissue which would be expected to decline in aging 
epithelia and AE (Figure 7).  
Interestingly, no a-SMA-positive fibroblasts were detected in any of the stromal 
compartments, but instead a-SMA was only localized to blood vessels (Figure 5). 
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Similarly, Mahajan et al. (2020) did not find a-SMA-positive myofibroblasts residing in 
normal oral stroma or around dysplastic epithelia. Instead, a-SMA-positive 
myofibroblasts were found in OSCC samples. It has been suggested that for fibroblasts to 
transform into a-SMA-positive myofibroblasts, there must be paracrine signaling 
between OSCC cells and fibroblasts (Kellermann et al.,2008; Lewis et al., 2004). 
Because no OSCC regions were found in the aging tissue sections treated with 4NQO, 
this could explain an absence in a-SMA-positive myofibroblasts in our study. 
Changes in epithelial differentiation during aging have been shown to be due to 
the accumulation of senescent fibroblasts (Elkhattouti et al., 2015). Although we did not 
see changes in fibroblasts in the non-treated aging epithelia, this may be due to the fact 
that our tissues were derived from mice that were not sufficiently aged. Indeed, a 
previous study of normal and aged breast epithelial cells showed that cellular senescence 
played a critical role in driving tumorigenesis (Chaturvedi & Hass, 2011). In addition, 
other studies confirmed that the presence of senescent fibroblasts was the cause of 
epithelial cell proliferation and acquisition of migratory phenotypes (Elkhattouti et al., 
2015; Krtolica et al., 2001), as observed in our aging dysplastic oral epithelia from the 
4NQO-treated mice (Figure 5D). Future studies using much older mice (> 60 weeks) will 
provide more information about how aging impacts the stromal compartment, as well as 
the development of OSCC and its progression to advanced disease.  
The presence of myofibroblasts in the aging 4NQO-treated stroma could be due to 
the aging process. Myofibroblasts can be derived from senescent fibroblasts in response 
to oncogenic signals (Kakarla et al., 2012). Although we did not stain for factors released 
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by SASP fibroblasts in the aging microenvironment, these factors have been shown to 
transform fibroblast cell lines (Elkhattouti et al., 2015). In a study of aged fibroblasts, the 
aged secretome promoted EMT in elderly keratinocytes (Tinaburri et al., 2021). The 
latter study proposed that the accumulation of senescent cells promoted cell 
dedifferentiation and tumor initiation. Furthermore, in a young microenvironment, 
squamous cell carcinoma invasion was not observed when the ECM contained young 
fibroblasts (Tinaburri et al., 2021). Collectively, the above findings support our 
hypothesis that aging drives changes in oral epithelia and the microenvironment as 
documented by cellular dedifferentiation and atypical endophytic growth. The latter may 
be due to the presence of PDGFRb-positive cells and other senescent populations in the 
aging tissue. In this study, PDGFRb-positive fibroblasts in the aging stroma could also 
arise from senescence in combination with the effects of the 4NQO carcinogen (Figure 
8). Further studies of the role of PDGFRb-positive fibroblasts in aged oral epithelial are 
needed, as in non-small cell lung cancer (NSCLC), PDGFRb tumor levels did not 
correlate with age through IHC staining (Tsao et al., (2011).  
In our study, both a-SMA and PDGFRb  localized to pericytes in all tissue 
sections. Evaluation of the lamina propria regions in the non-treated aging tissue sections 
revealed a slight decrease in the staining of pericytes compared to the lamina propria 
from young mice (Figure 5A-B). Such a depletion of pericytes and capillaries with aging 
has been reported in old murine kidneys and to be due to cellular senescence (Stefanska 
et al., 2015). Significantly, a subset of pericytes was found to differentiate into 
myofibroblast with aging. Additionally, in the aged 4NQO-treated tissue, we found an 
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increase in vascular structures around epithelial dysplasia (Figure 5E). Since 
angiogenesis is needed for tumor growth, this increase in vasculature may be a sign of 
tumor initiation in the aging 4NQO-treated tissue. Indeed, increased vascularization 
during progression from normal epithelium to OSCC has been reported (Jyothsna et al., 
2017). The increase in vasculature may be also explained by the accumulation of SASP 
fibroblasts as they have been shown to secrete factors that promote new vessel formation 
(Fane & Weeraratna, 2020). Taken together, such increased population of senescent 
fibroblasts, myofibroblasts, SASP fibroblasts and vasculature in aging oral tissues may 
lead to a tumor permissive microenvironment and explain why OSCC is more common in 
aged head and neck cancer patients. 
 
Limitations 
Many of the proteins of interest in this study could not be analyzed by IHC or in 
mouse tissues due to the lack of availability of specific antibodies.  
 
Future Studies  
Future studies will utilize 4NQO-induced oral tumor-derived OSCC mouse cell 
lines, 4MOSC1 and 4MOSC2, shown to generate tumor xenografts with mutational 
features closely resembling human OSCC (Wang et al., 2019). The experimental 
approach will involve characterization of 4MOSC cell-line derived tumors implanted into 
the tongues of young and aged (>60 weeks) mice. This will allow us to carry out detailed 
characterization of TME in young and aged mice and to align any changes in biomarkers 
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and cell types with tumor development and progression to advanced disease. Since there 
are limited studies on how aging impacts the oral microenvironment, identification of 
senescent fibroblasts and CAFs and their secretions to determine how the ECM is 
modified in OSCC would provide valuable insights into as yet unidentified factors’ 
contribution to OSCC development and progression to metastatic disease.  
 These approaches will also facilitate characterization of the immune landscape at 
early stages of OSCC development and progression to metastasis. Previous studies have 
shown that aging is accompanied by a decrease in immune surveillance and an increase in 
inflammation (Fane & Weeraratna, 2020). Examination of different components of the 
immune system in young and aged oral tissues and their response to tumor development 
and progression would provide critical insights into the mechanisms underlying oral 
cancer. Indeed, older mice have been shown to have higher incidence of dysplasia and 
OSCC, which could be explained by immunosenescence (Vincent-Chong et al., 2018). 
Therapeutics can target these components and immune checkpoints to enhance response 
to immunotherapies. Furthermore, the innate and adaptive immune responses in adult 
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While age is a known contributing risk factor for the development of OSCC, there 
has been limited preclinical research on the role of aging in creating a tumor-permissive 
microenvironment that supports tumor growth and progression to malignant disease. This 
study confirms previous reports that aging plays a role in the dynamic changes of oral 
tissue epithelia and microenvironment likely to be critical for the development of OSCC 
in aged tissues.  The increase in a-SMA and PDGFRb expression in the vasculature 
suggests that these early precancerous lesions are progressing to OSCC. Further, the 
decrease in E-cadherin coincident with the increase in a-SMA expression appears to be a 
feature of dysplasia. The observed changes in biomarkers and cell phenotypes can be 
explained by the accumulation of senescent cell populations in aging oral tissues likely to 
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